Abstract
CYP2C9 and CYP2C19 are important drug metabolizing enzymes and together metabolize about 18% of currently available drugs. Some of the important groups of drugs that are metabolized by them are antihypertensives, hypoglycemics, anticonvulsants, antiulcer drugs etc. Genes encoding these enzymes are polymorphically expressed. Thirty variant alleles for CYP2C9 and 21 for CYP2C19 have been reported. The frequencies of these polymorphic alleles show marked inter-ethnic variation. Several reports have been published showing the clinical importance of this polymorphism. This review summarizes the currently available important information on this topic.
Keywords: CYP2C9 variant alleles, Phenytoin, Hypoglycemic Agents, Warfarin, Adverse Drug Reactions, Inter-ethnic variation
Current Clinical Pharmacology
Title: The Pharmacogenetics of CYP2C9 and CYP2C19: Ethnic Variation and Clinical Significance
Volume: 2 Issue: 1
Author(s): J. Rosemary and C. Adithan
Affiliation:
Keywords: CYP2C9 variant alleles, Phenytoin, Hypoglycemic Agents, Warfarin, Adverse Drug Reactions, Inter-ethnic variation
Abstract: CYP2C9 and CYP2C19 are important drug metabolizing enzymes and together metabolize about 18% of currently available drugs. Some of the important groups of drugs that are metabolized by them are antihypertensives, hypoglycemics, anticonvulsants, antiulcer drugs etc. Genes encoding these enzymes are polymorphically expressed. Thirty variant alleles for CYP2C9 and 21 for CYP2C19 have been reported. The frequencies of these polymorphic alleles show marked inter-ethnic variation. Several reports have been published showing the clinical importance of this polymorphism. This review summarizes the currently available important information on this topic.
Export Options
About this article
Cite this article as:
Rosemary J. and Adithan C., The Pharmacogenetics of CYP2C9 and CYP2C19: Ethnic Variation and Clinical Significance, Current Clinical Pharmacology 2007; 2 (1) . https://dx.doi.org/10.2174/157488407779422302
DOI https://dx.doi.org/10.2174/157488407779422302 |
Print ISSN 1574-8847 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3938 |
Related Articles
-
A Dig Deep to Scout the Pharmacological and Clinical Facet of Garlic
(<i>Allium sativum</i>)
Current Traditional Medicine From Multiple PAR1 Receptor/Protein Interactions to their Multiple Therapeutic Implications
Current Topics in Medicinal Chemistry Long-Term Effects of Perinatal Glucocorticoid Treatment on the Heart
Current Pediatric Reviews Adenosine Receptor Ligands in Clinical Trials
Current Topics in Medicinal Chemistry Immunosuppression in Liver Transplantation
Current Drug Targets Pathophysiology of Myocardial Infarction and Acute Management Strategies
Cardiovascular & Hematological Agents in Medicinal Chemistry PF-04886847 (an Inhibitor of Plasma Kallikrein) Attenuates Inflammatory Mediators and Activation of Blood Coagulation in Rat Model of Lipopolysaccharide (LPS) - Induced Sepsis
Cardiovascular & Hematological Agents in Medicinal Chemistry Pomolic Acid Isolated from the Leaves of Licania pittieri Inhibits ADP-and Epinephrine-Induced Platelet Aggregation and has Hypotensive Effect on Rats
Current Bioactive Compounds Therapeutic Effects of Renal Denervation on Renal Failure
Current Neurovascular Research Increased Production of Nitric Oxide Mediates Selective Organ-Specific Effects of Endotoxin on Oxidative Stress
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry What is Currently the Best Radiopharmaceutical for the Hybrid PET/CT Detection of Recurrent Medullary Thyroid Carcinoma?
Current Radiopharmaceuticals Twin-to-Twin Transfusion Syndrome: From Placental Anastomoses to Long-Term Neurodevelopmental Outcome
Current Pediatric Reviews Can We Move Forward After ADVANCE?
Vascular Disease Prevention (Discontinued) Arterial Hyperoxia in Severe Head Injury: A Useful or Harmful Option?
Current Pharmaceutical Design Prodrugs in Photodynamic Anticancer Therapy
Current Pharmaceutical Design Systemic Therapeutic Gene Delivery for Cancer: Crafting Paris Arrow
Current Gene Therapy Biochemical and Structural Investigations of Bothropstoxin-II, a Myotoxic Asp49 Phospholipase A2 from Bothrops jararacussu Venom
Protein & Peptide Letters Cardioprotective Potential of Iron Chelators and Prochelators
Current Medicinal Chemistry Essential Oils and Alcohol Extracts of Northwest Tunisia <i>M. communis</i> and <i>M. spicata</i>: Phytocompounds, Antioxidant and Antibacterial Activities
Current Bioactive Compounds Purine Derivatives as Ligands for A3 Adenosine Receptors
Current Topics in Medicinal Chemistry